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OBJECTIVE: The purpose of this study was to determine the levels of Cystatin C in healthy term newborns in the first
month of life.
INTRODUCTION: Cystatin C may be a suitable marker for determining the glomerular filtration rate because it is not
affected by maternal renal function.
METHODS: Cohort study. Inclusion: term newborns with appropriate weight; mother without renal failure or drugs
that could affect fetal glomerular filtration rate. Exclusion: malformations; hypertension or any condition that could
affect glomerular filtration rate. Cystatin C (mg/L) and creatinine (mg/dl) were determined in the mother (Mo) and
in the newborn at birth (Day-0), 3
rd (Day-3), 7
th(Day-7) and 28
th(Day-28) days. Statistics: one way ANOVA and
Pearson’s correlation tests. Sample size of 20 subjects for a = 5% and a power test = 80% (p,0.05).
RESULTS: Data from 21 newborns were obtained (mean ¡ standard deviation): MoCystatin C=1.00¡0.20; Day-0
Cystatin C 1.70¡0.26; Day-3 Cystatin C=1.51¡0.20; Day-7 Cystatin C=1.54¡0.10; Day-28 Cystatin
C=1.51¡0.10. MoCystatin C was smaller than Day-0 Cystatin C (p,0.001), while MoCreatinine was not different
from Day-0 Creatinine. Cystatin C only decreased from Day-0 to Day-3 (p=0.004) but newborns Creatinine decreased
along the time. Correlations were obtained between MoCystatin C and MoCreatinine (p=0.012), as well as Day-3
(p=0.047) and Day-28 (p=0.022) Cystatin C and Creatinine values.
CONCLUSION: Neonatal Cystatin C values were not affected by MoCystatin C and became stable from the 3
rd day of
life.
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INTRODUCTION
Newborns have a peculiar renal function and their
glomerular filtration rate may vary depending on the
degree of renal development at birth.
1
In newborns at term, the glomerular filtration rate reaches
values below 10% of the adult level, even when considered
in relation to body surface or weight. However, the
glomerular filtration rate increases progressively to adult
values only at 2 years of age.
2
In order to detect properly the presence of abnormal renal
function, it is crucial to understand the normal value of
expected glomerular filtration rate for each gestational and
postnatal age, using reliable methods for evaluation.
In general, renal function has been evaluated by the
creatinine clearance, which allows the glomerular filtration
rate estimation in regular conditions, but can overestimate
its value when glomerular filtration rate is less than 2 ml/
min/L.
2 In the neonatal period, because of the technical
difficulty in collecting urine for a few hours on a non
invasive procedure, serum creatinine has been used for the
evaluation of renal function.
3 However, creatinine depends
not only on its renal excretion, but also on its production
and metabolism. Moreover, at birth, it is a reflection of
maternal creatinine and it’s not known how long this effect
will last.
4 In order to find a more precise endogenous
marker of glomerular filtration rate, serum cystatin C has
been studied.
Cystatin C is a low molecular weight protein, freely
filtered by the glomerulus, and almost completely reab-
sorbed and metabolized in the proximal tubule. It is
produced on a constant rate by nucleated cells and its
serum concentration depends fundamentally of the glomer-
ular filtration rate.
5,6,7 It does not suffer interference of sex,
race, height or body composition,
8,9 but varies with the age
of the individual, being highest at birth, reducing up
progressively until 1 year of life,
10-13 when reaches levels
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217similar to those of adults. Unlike creatinine, serum cystatin
C in the newborn is not influenced by the mother’s renal
function,
14 which encourages its use to assess the
glomerular filtration rate soon after birth.
However, there are not yet standard values defined for
this period. This study aims at analyzing the evolution of
serum levels of cystatin C in healthy term newborns, during
the first month of life.
MATERIALS AND METHODS
A cohort study was carried out in the Nursery Annex to
the Maternity of Hospital das Clı ´nicas, University of Sa ˜o
Paulo, School of Medicine. It was performed in the period
from July 1
st 2005 to January 31
th, 2006. This research project
was approved by the Ethics Committee for Review of
Research Projects - CAPPesq of the hospital where it was
held, on March 24
st, 2005.
Newborns were included, according to the following
criteria: gestational age between 37 and 41
6/7 weeks (full
term newborns);
15,16 birth weight appropriate for gesta-
tional age;
17 first minute Apgar score equal to or higher than
7; and whose mother had given consent after being
adequately informed.
Exclusion criteria were: mothers with renal failure,
chronic or pregnancy-induced hypertension and use of
drugs that could have interfered with the fetal renal
function during pregnancy;
18 newborns with major or
kidney malformations; first diuresis after 12 hours of life
or diuresis between 24 and 72 hours of life less than 1 ml/
kg/h, weight loss until the third day of life higher than 10%
of the birth weight; hypertension;
19 heart or kidney failure;
hemolytic disease; jaundice needing phototherapy; infec-
tion; need for intravenous hydration or diuretics, vasoactive
or any drug use that could interfere with renal function; or
inability to collect all the samples as planed.
The newborns included received usual care according to
the rules of the neonatal unit. They were submitted in the
first three days of life to systematized clinical evaluation,
daily, always held by the same researcher which included
control of weight, length and blood pressure as described by
Zubrow
19 (monitor blood pressure noninvasive, oscilo-
metric - the DINAMAPH) and determination of 24 hours
diuresis. All outpatients returned to control at 7 and 28
days, and were evaluated clinically by the same person and
submitted to the weight, length and blood pressure control.
Blood was obtained for the determination of the labora-
tory cystatin C and creatinine of the mother at the time of
delivery, and in the newborn at birth in the umbilical
cord(Day-0), with 3(Day-3), 7 and 28(Day-28) days.
The cystatin C was measured in samples by immunone-
phelometry, using the Testkit N Latex Cystatin C, code
OQNM, manufactured by DADE BEHRINGH. The creati-
nine was determined by the method of Jaffe ´ without
desproteinization. All dosages were performed at the
Laboratory of Medical Research in Pediatric Clinic of the
Department of Pediatrics, University of Sa ˜o Paulo, School of
Medicine.
An ultrasound scan of the kidney and urinary tract until
the third day of life was done, always by the same person.
Statistical analysis
The sample size was calculated based on the mean serum
cystatin C (1.36 ¡ 0.35 mg/L)
20 and creatinine (0.50 ¡
0.30 mg/dl)
3 values and the objective was to detect
differences equal or greater than 0.24 mg/L (18%) for the
mean cystatin C concentrations and 0.20 mg/dl (40%) for
the creatinine values.
For an a of 5% and a power test (b) of 80%, the sample
was calculated on 20 newborns.
The comparisons between groups were made by the
paired Student t test or tests of non parametric Wilcoxon
Signed Rank Sum Friedman and 2-way ANOVA. The
Pearson’s correlation coefficient was used for correlation
analysis. The significance was set under 5% (p , 0.05).
RESULTS
21 newborns were included in the study.
The characterization of the study population can be seen
in Table 1. The evolution of weight in the 1
st month of life
has been as expected (Table 2). Throughout the study
period, 13 newborns had jaundice, without the need for
phototherapy (61.90%). One newborn had an atrial septal
defect and another one a ventricular septal defect, both
without repercussions and which were closed in the third
month of life. Blood pressure values were in accord with the
reference
19 (Figura 1).
As for the evaluation of diuresis, the first urination
occurred at 4.90 ¡ 3.90 hours of life, and the mean diuresis
in the Day-2 and Day-3 was of 2.10¡0.60 and 2.40¡
0.70 ml/kg/h, respectively, ranging from 1.30 to 3.70 ml/
kg/h. There were no differences between the diuresis in
these two days (p = 0.14) (Table 3).
All the ultrasound scans of the newborn kidneys and
urinary tracts were normal.
The newborn’s cystatin C values showed consistently
higher values than mother’s cystatin C. The maximum value
occurred on the Day- 0, getting their values stable from Day-
3 on. In turn, newborn creatinine did not differ from the
mother creatinine in the Day-0, and decreased progressively
until the Day-28 (table 4; figure 2).
The maternal cystatin C and creatinine concentrations
showed a positive correlation (r=0.537,p=0.012) as Day-
3(r=0.437;p=0.047) and Day-28(r=0.498;p=0.022) cystatin
C and creatinine values.
Table 1 - Characterization of the population (n = 21).
Mother characteristics
Age in years (mean ¡ standard deviation) 29.10 ¡ 8.20
1
st pregnancy (%) 28.60
Prenatal care (%) 100
Cesarean section (%) 52.40
Newborn characteristics
Gestational age (weeks) 39.40 ¡ 0.90
Birth Weight (g) 3224.30 ¡ 306.70
Adequate for Gestational Age (%) 100
Male (%) 57.10
Exclusive Breastfeeding (%) 81.00
Data presented as mean ¡ standard deviation or percent (%).
Table 2 - Weight evolution.
Loss of BW (%) 7.10 ¡ 1.70
Age at maximum weight loss (days) 2.40 ¡ 0.60
Weight at 28 days 4017.60 ¡ 376.30
Data presented as mean ¡ standard deviation or percent (%).BW-Birth
Weight
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The cystatin C comes out as a reliable marker of renal
function, particularly in the first week of life. However,
there was not yet in the literature determinations of serum
levels of cystatin C in healthy newborns, during the
neonatal period. In this study, it was possible to verify that
the newborn-term exhibit stable levels of cystatin C from the
third day of life and that there was not placental passage of
the cystatin C. In view of the need for the selection of case
series which were the closest possible to the normal, we
established a selection based on strict criteria for inclusion.
Furthermore, some clinical data were analyzed, such as:
weight, urine output, blood pressure and kidneys ultra-
sound, so that there was greater safety in relation to the
normal physiological development of renal function in these
newborns.
The included newborns had a weight loss that occurred
within the limits of 5 to 10%, considered normal for healthy
term newborns.
21 The first urination and urinary output
have remained within the expected.
2 The systolic and
diastolic blood pressure were always within the limits
considered normal for corrected gestational age,
19 ultra-
sonography kidneys evaluation showed no morphological
alterations and no disturb of thyroid function was detected.
Thus, it was possible to infer a diagnosis of normal renal
function of these newborns, which was corroborated by the
analysis of creatinine. On Day-0, creatinine was equal to the
mother, decreasing gradually to the Day-28. The levels of
creatinine were in line with the values considered normal
for healthy term newborns.
3,10
The mother creatinine was not different from that of the
newborn at birth, which was expected, given the known
placental passage of creatinine. In turn, the cystatin C of the
mother was different from the newborn cystatin C at birth,
as has been described by Cataldi , showing no placental
passage of the cystatin C.
14 The levels of maternal cystatin C
and creatinine were consistent with the values described by
Cataldi
14 and by Babay
22 and showed a correlation between
them, as expected, since a number of searches already
demonstrated the accuracy of cystatin C to estimate the
glomerular filtration rate and its correlation with creati-
nine.
10-14,20,23-26
The cystatin C in the newborns were higher on the Day-0,
decreasing from birth to the third day and then the levels
remained constant, always higher than the maternal ones.
Some authors have sought to determine the normal values
of cystatin C in term newborns in the neonatal period:
Bo ¨kenkamp
11 - 1.64 to 2.59 mg/L from 0 to 3 days and 1.52
to 2.40 mg/L from 3 to 30 days; Finney
10 - 0.81 to 2.32 mg/L
from 0 to 3 months; Harmoinen
13 - 1.36 to 2.23 mg/L from 0
to 7 days; Bahar
20 - 0.69 to 2.43 mg/L in the umbilical cord
and 0.78 to 2.40 mg/L to 3 days and Treiber
25 - 1.97 ¡
0.36 mg/L (1, 38 to 3.23) in the umbilical cord and 1.93 ¡
0.33 mg/L (1.28 to 2.66) in the third day. The results
obtained here are contained in each of these bands of
normal values, which are very large, since the age groups
were not always so restricted and the inclusion criteria to
ensure normal renal function were not as stringent as those
used here.
Figure 1 - NB blood pressure and post conceptual gestational age according to reference values of Zubrow
20.
Table 3 - Evaluation of Diuresis.
First urination (hours) 4.90 ¡ 3.90
Diuresis on the 2
nd day of life (ml/kg/h) 2.10 ¡ 0.60
Diuresis on the 3
rd day of life (ml/kg/h) 2.40 ¡ 0.70
Data presented as mean ¡ standard deviation.
Table 4 - Levels of cystatin C and creatinine.
Cystatin C (mg/L) Creatinine (mg/dl)
Mother 1.00 ¡ 0.20 0.63 ¡ 0.15
NB Day-0 1.70 ¡ 0.26 0.63 ¡ 0.15
Day-3 1.51 ¡ 0.19 0.48 ¡ 0.16
Day-7 1.54 ¡ 0.15 0.37 ¡ 0.10
Day-28 1.51 ¡ 0.15 0.26 ¡ 0.05
Data presented as mean ¡ standard deviation.
Creatinine: mother X Day-0, p = 0.545; Day-0 X Day-3, p = 0.007; Day-3 X
Day-7, p = 0.002; Day-7 X Day-28, p ,0.001.
Cistatina C: mother X Day-0, p ,0.001; Day-0 X Day-3, p = 0.004; Day-3 X
Day-7, p = 0.419; Day-7 X Day-28, p = 0.455.
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219We observed a positive correlation between the maternal
values of creatinine and cystatin C, as expected.
14,22 Besides
that other positive correlations were obtained on Day-3 and
Day-28 between cystatin C and creatinine values. The
significance of these results has yet to be proved, as the
glomerular filtration rate could not be studied by us through
clearances analysis as desirable because of methodological
limitations in term newborns.
It’s possible that cystatin C could be a reliable indicator of
renal function in newborns, especially in the first week of
life, for not having placental passage and being stable from
the third day of life.
Nevertheless, from the results obtained in this study, we
only can indicate these values of cystatin C as reference
serum levels for healthy term newborns. New studies are
needed in order to evaluate the reliability of newborn
cystatin C values as a marker of renal function in the
neonatal period.
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